Skip to main content

An engine for new medicines: A century of science changing life

Calibr, a nonprofit research institute founded by Scripps Research President and CEO Pete Schultz, joined Scripps Research in 2018 as its drug discovery division. As a world-class nonprofit “bench to bedside” drug discovery engine, Calibr delivers groundbreaking solutions to unmet medical needs by uniting the creativity of fundamental discovery with highly focused R&D capabilities and expertise.

Centennial

Calibr-Skaggs Drug Discovery Aging & Healthspan Cancer Centennial Drug Discovery Infectious Diseases multiple sclerosis Neurological Disorders

Groundbreaking Science.
Life-changing Medicine.